{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,3]],"date-time":"2026-03-03T15:57:02Z","timestamp":1772553422437,"version":"3.50.1"},"reference-count":45,"publisher":"Elsevier BV","issue":"4","license":[{"start":{"date-parts":[[2015,7,1]],"date-time":"2015-07-01T00:00:00Z","timestamp":1435708800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":["tuberculosisjournal.com","clinicalkey.jp","clinicalkey.com","clinicalkey.es","clinicalkey.com.au","clinicalkey.fr","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Tuberculosis"],"published-print":{"date-parts":[[2015,7]]},"DOI":"10.1016\/j.tube.2015.03.012","type":"journal-article","created":{"date-parts":[[2015,4,17]],"date-time":"2015-04-17T20:45:24Z","timestamp":1429303524000},"page":"432-439","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":10,"title":["Development of a Mycobacterium smegmatis transposon mutant array for characterising the mechanism of action of tuberculosis drugs: Findings with isoniazid and its structural analogues"],"prefix":"10.1016","volume":"95","author":[{"given":"Richard L.","family":"Campen","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"David F.","family":"Ackerley","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Gregory M.","family":"Cook","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ronan F.","family":"O'Toole","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.tube.2015.03.012_bib1","series-title":"Global tuberculosis report","author":"World Health Organisation","year":"2014"},{"key":"10.1016\/j.tube.2015.03.012_bib2","series-title":"Global plan to stop TB","author":"WHO. World Health Organisation and the Stop TB Partnership","year":"2006"},{"key":"10.1016\/j.tube.2015.03.012_bib3","series-title":"Treatment of tuberculosis: guidelines","author":"World Health Organization","year":"2010"},{"key":"10.1016\/j.tube.2015.03.012_bib4","series-title":"Building on and enhancing DOTS to meet the TB-related millennium development goals","author":"WHO. World Health Organisation and the Stop TB Partnership","year":"2006"},{"key":"10.1016\/j.tube.2015.03.012_bib5","doi-asserted-by":"crossref","first-page":"267","DOI":"10.1128\/AAC.46.2.267-274.2002","article-title":"Evolution of drug resistance in Mycobacterium tuberculosis: clinical and molecular perspective","volume":"46","author":"Gillespie","year":"2002","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1016\/j.tube.2015.03.012_bib6","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1016\/j.tube.2003.08.003","article-title":"M.\u00a0tuberculosis persistence, latency, and drug tolerance","volume":"84","author":"Gomez","year":"2004","journal-title":"Tuberc (Edinb)"},{"key":"10.1016\/j.tube.2015.03.012_bib7","doi-asserted-by":"crossref","first-page":"677","DOI":"10.1001\/jama.282.7.677","article-title":"Consensus statement. Global burden of tuberculosis: estimated incidence, prevalence, and mortality by country. WHO global surveillance and monitoring project","volume":"282","author":"Dye","year":"1999","journal-title":"J\u00a0Am Med Assoc"},{"key":"10.1016\/j.tube.2015.03.012_bib8","doi-asserted-by":"crossref","first-page":"158","DOI":"10.1002\/emmm.201201772","article-title":"Tuberculosis drug discovery in the post-post-genomic era","volume":"6","author":"Lechartier","year":"2014","journal-title":"EMBO Mol Med"},{"key":"10.1016\/j.tube.2015.03.012_bib9","doi-asserted-by":"crossref","first-page":"513","DOI":"10.1016\/S1471-4892(02)00197-2","article-title":"New (and not so new) antibacterial targets \u2013 from where and when will the novel drugs come?","volume":"2","author":"Projan","year":"2002","journal-title":"Curr Opin Pharmacol"},{"key":"10.1016\/j.tube.2015.03.012_bib10","doi-asserted-by":"crossref","first-page":"576","DOI":"10.1016\/j.tips.2008.08.001","article-title":"Rising standards for tuberculosis drug development","volume":"29","author":"Balganesh","year":"2008","journal-title":"Trends Pharmacol Sci"},{"key":"10.1016\/j.tube.2015.03.012_bib11","doi-asserted-by":"crossref","first-page":"901","DOI":"10.1016\/S0092-8674(01)00286-0","article-title":"Structural mechanism for rifampicin inhibition of bacterial rna polymerase","volume":"104","author":"Campbell","year":"2001","journal-title":"Cell"},{"key":"10.1016\/j.tube.2015.03.012_bib12","doi-asserted-by":"crossref","first-page":"e75245","DOI":"10.1371\/journal.pone.0075245","article-title":"Identification of new drug targets and resistance mechanisms in Mycobacterium tuberculosis","volume":"8","author":"Ioerger","year":"2013","journal-title":"PLoS ONE"},{"key":"10.1016\/j.tube.2015.03.012_bib13","doi-asserted-by":"crossref","first-page":"13947","DOI":"10.1021\/bi061874m","article-title":"Proteome-wide profiling of isoniazid targets in Mycobacterium tuberculosis","volume":"45","author":"Argyrou","year":"2006","journal-title":"Biochemistry"},{"key":"10.1016\/j.tube.2015.03.012_bib14","doi-asserted-by":"crossref","first-page":"54","DOI":"10.1021\/pr050248t","article-title":"Quantitative proteomic analysis of drug-induced changes in mycobacteria","volume":"5","author":"Hughes","year":"2006","journal-title":"J\u00a0Proteome Res"},{"key":"10.1016\/j.tube.2015.03.012_bib15","doi-asserted-by":"crossref","first-page":"40174","DOI":"10.1074\/jbc.M406796200","article-title":"The transcriptional responses of Mycobacterium tuberculosis to inhibitors of metabolism: novel insights into drug mechanisms of action","volume":"279","author":"Boshoff","year":"2004","journal-title":"J\u00a0Biol Chem"},{"key":"10.1016\/j.tube.2015.03.012_bib16","doi-asserted-by":"crossref","first-page":"223","DOI":"10.1126\/science.1106753","article-title":"A\u00a0diarylquinoline drug active on the ATP synthase of Mycobacterium tuberculosis","volume":"307","author":"Andries","year":"2005","journal-title":"Science"},{"key":"10.1016\/j.tube.2015.03.012_bib17","doi-asserted-by":"crossref","first-page":"227","DOI":"10.1126\/science.8284673","article-title":"inhA, a gene encoding a target for isoniazid and ethionamide in Mycobacterium tuberculosis","volume":"263","author":"Banerjee","year":"1994","journal-title":"Science"},{"key":"10.1016\/j.tube.2015.03.012_bib18","doi-asserted-by":"crossref","first-page":"11919","DOI":"10.1073\/pnas.93.21.11919","article-title":"The embAB genes of Mycobacterium avium encode an arabinosyl transferase involved in cell wall arabinan biosynthesis that is the target for the antimycobacterial drug ethambutol","volume":"93","author":"Belanger","year":"1996","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.1016\/j.tube.2015.03.012_bib19","doi-asserted-by":"crossref","first-page":"62","DOI":"10.1038\/nbt919","article-title":"Integration of chemical-genetic and genetic interaction data links bioactive compounds to cellular target pathways","volume":"22","author":"Parsons","year":"2004","journal-title":"Nat Biotechnol"},{"key":"10.1016\/j.tube.2015.03.012_bib20","doi-asserted-by":"crossref","first-page":"611","DOI":"10.1016\/j.cell.2006.06.040","article-title":"Exploring the mode-of-action of bioactive compounds by chemical-genetic profiling in yeast","volume":"126","author":"Parsons","year":"2006","journal-title":"Cell"},{"issue":"5","key":"10.1016\/j.tube.2015.03.012_bib21","doi-asserted-by":"crossref","first-page":"1473","DOI":"10.1128\/JCM.02993-14","article-title":"Clinical application of whole genome sequencing to inform treatment for multi-drug resistant tuberculosis cases","volume":"53","author":"Witney","year":"2015","journal-title":"J\u00a0Clin Microbiol"},{"key":"10.1016\/j.tube.2015.03.012_bib22","doi-asserted-by":"crossref","first-page":"e0117771","DOI":"10.1371\/journal.pone.0117771","article-title":"Whole genome sequencing based characterization of extensively drug-resistant Mycobacterium tuberculosis isolates from Pakistan","volume":"10","author":"Ali","year":"2015","journal-title":"PLoS ONE"},{"key":"10.1016\/j.tube.2015.03.012_bib23","first-page":"1","article-title":"Whole genome sequencing: a new paradigm in the surveillance and control of human tuberculosis","author":"Hasnain","year":"2015","journal-title":"Tuberculosis"},{"issue":"237","key":"10.1016\/j.tube.2015.03.012_bib24","first-page":"239","article-title":"Chemical-genetic approaches for exploring the mode of action of natural products","volume":"66","author":"Lopez","year":"2008","journal-title":"Prog Drug Res"},{"key":"10.1016\/j.tube.2015.03.012_bib25","doi-asserted-by":"crossref","first-page":"12712","DOI":"10.1073\/pnas.231275498","article-title":"Comprehensive identification of conditionally essential genes in mycobacteria","volume":"98","author":"Sassetti","year":"2001","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.1016\/j.tube.2015.03.012_bib26","doi-asserted-by":"crossref","first-page":"535","DOI":"10.1128\/jb.176.2.535-539.1994","article-title":"Efficient transposition in mycobacteria: construction of Mycobacterium smegmatis insertional mutant libraries","volume":"176","author":"Guilhot","year":"1994","journal-title":"J\u00a0Bacteriol"},{"key":"10.1016\/j.tube.2015.03.012_bib27","doi-asserted-by":"crossref","first-page":"12","DOI":"10.1016\/j.tube.2008.07.007","article-title":"Nitrile-inducible gene expression in mycobacteria","volume":"89","author":"Pandey","year":"2009","journal-title":"Tuberc (Edinb)"},{"key":"10.1016\/j.tube.2015.03.012_bib28","first-page":"651","article-title":"Detection of inhibitors of phenotypically drug-tolerant Mycobacterium tuberculosis using an in\u00a0vitro bactericidal screen","volume":"51","author":"Bassett","year":"2013","journal-title":"J\u00a0Microbiol"},{"issue":"Pt 9","key":"10.1016\/j.tube.2015.03.012_bib29","doi-asserted-by":"crossref","first-page":"2185","DOI":"10.1099\/00221287-146-9-2185","article-title":"Characterization of IS900 loci in Mycobacterium avium subsp. paratuberculosis and development of multiplex PCR typing","volume":"146","author":"Bull","year":"2000","journal-title":"Microbiology"},{"key":"10.1016\/j.tube.2015.03.012_bib30","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1111\/j.1574-6968.1996.tb08507.x","article-title":"Analysis of isoniazid-resistant transposon mutants of Mycobacterium smegmatis","volume":"144","author":"Billman-Jacobe","year":"1996","journal-title":"FEMS Microbiol Lett"},{"key":"10.1016\/j.tube.2015.03.012_bib31","doi-asserted-by":"crossref","first-page":"1647","DOI":"10.1093\/bioinformatics\/bts199","article-title":"Geneious basic: an integrated and extendable desktop software platform for the organization and analysis of sequence data","volume":"28","author":"Kearse","year":"2012","journal-title":"Bioinformatics"},{"key":"10.1016\/j.tube.2015.03.012_bib32","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1016\/j.plasmid.2010.04.003","article-title":"Improved mycobacterial tetracycline inducible vectors","volume":"64","author":"Williams","year":"2010","journal-title":"Plasmid"},{"key":"10.1016\/j.tube.2015.03.012_bib33","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1016\/0378-1119(95)00685-0","article-title":"FACS-optimized mutants of the green fluorescent protein (GFP)","volume":"173","author":"Cormack","year":"1996","journal-title":"Gene"},{"key":"10.1016\/j.tube.2015.03.012_bib34","doi-asserted-by":"crossref","first-page":"1375","DOI":"10.1111\/j.1365-2958.2011.07892.x","article-title":"Comparative analysis of mycobacterial NADH pyrophosphatase isoforms reveals a novel mechanism for isoniazid and ethionamide inactivation","volume":"82","author":"Wang","year":"2011","journal-title":"Mol Microbiol"},{"key":"10.1016\/j.tube.2015.03.012_bib35","doi-asserted-by":"crossref","first-page":"879","DOI":"10.1046\/j.1365-2958.2001.02427.x","article-title":"Regulation of catalase-peroxidase (KatG) expression, isoniazid sensitivity and virulence by furA of Mycobacterium tuberculosis","volume":"40","author":"Pym","year":"2001","journal-title":"Mol Microbiol"},{"key":"10.1016\/j.tube.2015.03.012_bib36","doi-asserted-by":"crossref","first-page":"2347","DOI":"10.1093\/jac\/dkq311","article-title":"Targeting the chromosome partitioning protein ParA in tuberculosis drug discovery","volume":"65","author":"Nisa","year":"2010","journal-title":"J\u00a0Antimicrob Chemother"},{"key":"10.1016\/j.tube.2015.03.012_bib37","doi-asserted-by":"crossref","first-page":"839","DOI":"10.1517\/17460441.2011.586999","article-title":"Navigating tuberculosis drug discovery with target-based screening","volume":"6","author":"Miller","year":"2011","journal-title":"Expert Opin Drug Discov"},{"key":"10.1016\/j.tube.2015.03.012_bib38","doi-asserted-by":"crossref","first-page":"2834","DOI":"10.1074\/jbc.272.5.2834","article-title":"Overexpression, purification, and characterization of the catalase-peroxidase KatG from Mycobacterium tuberculosis","volume":"272","author":"Johnsson","year":"1997","journal-title":"J\u00a0Biol Chem"},{"key":"10.1016\/j.tube.2015.03.012_bib39","doi-asserted-by":"crossref","first-page":"98","DOI":"10.1126\/science.279.5347.98","article-title":"Modification of the NADH of the isoniazid target (InhA) from Mycobacterium tuberculosis","volume":"279","author":"Rozwarski","year":"1998","journal-title":"Science"},{"key":"10.1016\/j.tube.2015.03.012_bib40","doi-asserted-by":"crossref","first-page":"2588","DOI":"10.1002\/(SICI)1521-3773(19990903)38:17<2588::AID-ANIE2588>3.0.CO;2-8","article-title":"Spontaneous formation of the bioactive form of the tuberculosis drug isoniazid","volume":"38","author":"Wilming","year":"1999","journal-title":"Angew Chem Int Ed Engl"},{"key":"10.1016\/j.tube.2015.03.012_bib41","doi-asserted-by":"crossref","first-page":"591","DOI":"10.1038\/358591a0","article-title":"The catalase-peroxidase gene and isoniazid resistance of Mycobacterium tuberculosis","volume":"358","author":"Zhang","year":"1992","journal-title":"Nature"},{"key":"10.1016\/j.tube.2015.03.012_bib42","doi-asserted-by":"crossref","first-page":"354","DOI":"10.1016\/S0966-842X(98)01307-9","article-title":"Interdependence of mycobacterial iron regulation, oxidative-stress response and isoniazid resistance","volume":"6","author":"Dussurget","year":"1998","journal-title":"Trends Microbiol"},{"key":"10.1016\/j.tube.2015.03.012_bib43","doi-asserted-by":"crossref","first-page":"795","DOI":"10.1016\/S1097-2765(00)80079-9","article-title":"Alkyl hydroperoxide reductase subunit C (AhpC) protects bacterial and human cells against reactive nitrogen intermediates","volume":"1","author":"Chen","year":"1998","journal-title":"Mol Cell"},{"key":"10.1016\/j.tube.2015.03.012_bib44","doi-asserted-by":"crossref","first-page":"1641","DOI":"10.1126\/science.272.5268.1641","article-title":"Compensatory ahpC gene expression in isoniazid-resistant Mycobacterium tuberculosis","volume":"272","author":"Sherman","year":"1996","journal-title":"Science"},{"key":"10.1016\/j.tube.2015.03.012_bib45","doi-asserted-by":"crossref","first-page":"75","DOI":"10.1111\/j.1574-6968.1998.tb12803.x","article-title":"A\u00a0reliable amplification technique for the characterization of genomic DNA sequences flanking insertion sequences","volume":"158","author":"Prod'hom","year":"1998","journal-title":"FEMS Microbiol Lett"}],"container-title":["Tuberculosis"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1472979215207494?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1472979215207494?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2019,8,23]],"date-time":"2019-08-23T14:34:28Z","timestamp":1566570868000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1472979215207494"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2015,7]]},"references-count":45,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2015,7]]}},"alternative-id":["S1472979215207494"],"URL":"https:\/\/doi.org\/10.1016\/j.tube.2015.03.012","relation":{},"ISSN":["1472-9792"],"issn-type":[{"value":"1472-9792","type":"print"}],"subject":[],"published":{"date-parts":[[2015,7]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Development of a Mycobacterium smegmatis transposon mutant array for characterising the mechanism of action of tuberculosis drugs: Findings with isoniazid and its structural analogues","name":"articletitle","label":"Article Title"},{"value":"Tuberculosis","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.tube.2015.03.012","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2015 Elsevier Ltd. All rights reserved.","name":"copyright","label":"Copyright"}]}}